Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
- 21 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (2), 414-426
- https://doi.org/10.1021/jm049575n
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Fragment-Based Lead Discovery Using X-ray CrystallographyJournal of Medicinal Chemistry, 2004
- Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)Journal of Medicinal Chemistry, 2003
- Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP KinaseJournal of Medicinal Chemistry, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- High-throughput crystallography for lead discovery in drug designNature Reviews Drug Discovery, 2002
- Molecular Basis for p38 Protein Kinase Inhibitor SpecificityBiochemistry, 1998
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Biological Control and Refuge TheoryScience, 1994
- Free R value: a novel statistical quantity for assessing the accuracy of crystal structuresNature, 1992
- Some Chlorinated 4-Indanols: Preparation and Proof of Structures1Journal of the American Chemical Society, 1957